Loading
Cancer treatment often damages sexual function and intimacy, and almost nobody asks. Make it a routine question with a clinic to refer to.
Sexual dysfunction after pelvic surgery, radiotherapy, endocrine therapy and stem cell transplant is very common and is among the least discussed toxicities. The proposal is routine screening with a brief validated item set at treatment milestones, a referral pathway to sexual health services (pelvic floor physiotherapy, vaginal and erectile therapies, counselling), and inclusion of sexual function as a PRO domain in trials of pelvic and endocrine treatments.
Shares Symptomatic toxicities experienced during anticancer treatment: agreement between patient and physician reporting in three randomized trials, Survivorship and late effects are neglected, Toxicity and quality of life are undervalued.
Shares Partners and relationships after cancer: what the divorce data actually show, Survivorship and late effects are neglected, Cervical cancer, HR-positive / HER2-negative breast cancer.
Shares Body image after cancer treatment: how it is measured, what drives it, and what helps, Sexual function and intimacy after cancer, for both sexes, Colorectal cancer.
Shares Body image after cancer treatment: how it is measured, what drives it, and what helps, Sexual function and intimacy after cancer, for both sexes, Survivorship and late effects are neglected, Toxicity and quality of life are undervalued.
Shares Symptomatic toxicities experienced during anticancer treatment: agreement between patient and physician reporting in three randomized trials, Toxicity and quality of life are undervalued, HR-positive / HER2-negative breast cancer, Colorectal cancer.
Shares Sexual function and intimacy after cancer, for both sexes, Survivorship and late effects are neglected, Toxicity and quality of life are undervalued, Cervical cancer.
Shares Symptomatic toxicities experienced during anticancer treatment: agreement between patient and physician reporting in three randomized trials, Toxicity and quality of life are undervalued.
Shares Symptomatic toxicities experienced during anticancer treatment: agreement between patient and physician reporting in three randomized trials, Toxicity and quality of life are undervalued.